2002Drug News & PerspectivesRequires access

Trk neurotrophin receptor activators

Scott J. Pollack, Simon Harper

Open publisher page 8 citations

Abstract

The neurotrophins are a small group of proteins whose binding at the tropomyosin related kinase (Trk) and p75 neurotrophin receptor transmembrane receptors triggers a cascade of signaling events that give rise to neurotrophic responses in neuronal cells and in vivo. Although neurotrophins have been evaluated for therapy for several human neurodegenerative diseases, their poor pharmacokinetic behavior has rendered their development largely unsuccessful. For this reason, several strategies are being explored to obtain small molecules that achieve the neurotrophic and neuroprotective effects attributed to neurotrophins. One strategy in which to achieve these effects is to develop compounds that affect Trk receptor activation. (c) 2002 Prous Science. All rights reserved.

About this research paper

What this paper is about

The neurotrophins are a small group of proteins whose binding at the tropomyosin related kinase (Trk) and p75 neurotrophin receptor transmembrane receptors triggers a cascade of signaling events that give rise to neurotrophic responses in neuronal cells and in vivo. Although neurotrophins have been evaluated for therapy for several human neurodegenerative diseases, their poor pharmacokinetic behavior has rendered their development largely unsuccessful. For this reason, several strategies are being explored to obtain small molecules that achieve the neurotrophic and neuroprotective effects attributed to neurotrophins. One strategy in which to achieve these effects is to develop compounds that affect Trk receptor activation. (c) 2002 Prous Science. All rights reserved.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The neurotrophins are a small group of proteins whose binding at the tropomyosin related kinase (Trk) and p75 neurotrophin receptor transmembrane receptors triggers a cascade of signaling events that give rise to neurotrophic responses in neuronal cells and in vivo. Although neurotrophins have been evaluated for therapy for several human neurodegenerative diseases, their poor pharmacokinetic behavior has rendered their development largely unsuccessful. For this reason, several strategies are being explored to obtain small molecules that achieve the neurotrophic and neuroprotective effects attributed to neurotrophins. One strategy in which to achieve these effects is to develop compounds that affect Trk receptor activation. (c) 2002 Prous Science. All rights reserved.

Key concepts: Trk receptor, Neurotrophin, Low-affinity nerve growth factor receptor, Tropomyosin receptor kinase B, Neuroprotection, Tropomyosin receptor kinase C, Receptor, Tropomyosin receptor kinase A

Related papers

Back to paper searchBrowse research topicsOriginal source
Trk neurotrophin receptor activators — Research Paper | ScholarLens